ENSG vs TECH
Ensign Group vs Bio-Techne — AI-powered side-by-side comparison
| Metric | ENSG | TECH |
|---|
| AI Score |
68
|
71
|
| Price |
$181.61
|
$72.42
|
| P/E Ratio |
27.65×
|
61.88×
|
| ROE |
15.4%
|
8.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.1%
|
65.8%
|
| Debt / Equity |
0.92×
|
0.13×
|
| Dividend Yield |
0.1%
|
0.4%
|
| RSI (14) |
61.1
|
63.6
|
| Beta |
0.694
|
1.277
|
| Expected Upside |
+6.6%
|
—
|
AI Committee View
Current Innellis committee reasoning for ENSG versus TECH.
TECH leads by 3 points.
TECH scores 71/100 (Buy) versus ENSG at 68/100 (Buy).
ENSG Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.06) -- balance sheet can absorb a shock. The main limiting factor is p/e of 28.0 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 16.5% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 28.0 is moderate-to-rich — Value
- Price-to-book of 4.5x prices in significant intangible value — Value
TECH Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical